Biotechnology Cancer Cures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (80)	6/28/1999 8:46:00 AM
From: WWS	Read Replies (1) of 226

Richard, Making the rounds on TV news this weekend are the UCLA studies (headed by Mark Pegram) using adenovirsus to insert normal p53 genes into patients with advanced ovarian cancers. I could find nothing on Dr. Pegram's research in the print media, although I was able to find reference to research sounding very similar from Muller and Coleman at U.Texas SW Medical Ctr in Dallas (see URL below). Have you come across any written reference to the Pegram research? Have you heard discussions or presentations of results of such research either at UCLA or elsewhere? This sounds as if it may be a promising "last resort" treatment for my friend. eurekalert.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next